Related Experiment Video
Updated: Jun 21, 2026
06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
[Locomotion disturbances in Huntington's disease]
1EA2683, IFR 114, service de neurologie et de neurophysiologie clinique, hôpital Salengro, CHRU de Lille, 59037 Lille cedex, France. a-delval@chru-lille.fr
Revue Neurologique
|July 17, 2009
Summary
Huntington's disease (HD) causes early gait timing and stride length issues, increasing fall risks. Current therapies like metronomes are ineffective, possibly due to attention deficits in HD patients.
Area of Science:
- Neurology
- Movement Disorders
Context:
- Huntington's disease (HD) is a neurodegenerative disorder.
- Locomotion disturbances, including gait impairments, are early clinical features of HD.
Purpose:
- To define the nature of gait disorders in Huntington's disease.
- To explore the challenges in developing therapeutic strategies for gait impairments in HD.
Summary:
- Gait disorders in HD are characterized as a timing issue, with hypokinesia (reduced stride length) becoming significant as the disease progresses.
- These gait impairments elevate the risk of falls, with factors and consequences varying by disease stage.
- Current interventions, such as metronome-assisted gait training, have shown limited efficacy, potentially due to attention deficits in HD patients.
Impact:
- Understanding HD-related gait disturbances is crucial for fall prevention and management.
- The ineffectiveness of current gait therapies highlights the need for novel therapeutic approaches.
- Further research is needed to evaluate the impact of antichoreic medications on specific gait parameters in HD.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...